Insulin Analogs: Non-inferior and Expensive

Abstract

  The tremendous rise in the cost of insulin has been due mostly to the high cost of synthetic insulin analogs.  The onset and duration of action of insulin analogs are more predictable than human insulin. For this reason, patients generally prefer to use analogs, but head-tohead comparisons of analogs to human insulin have not shown major net differences in clinical outcomes.